ABOUT CELYAD ONCOLOGY
Celyad Oncology is a clinical-stage biotechnology company focused on the discovery and development of chimeric antigen receptor T cell (CAR T) therapies for cancer
Latest News

Our SCIENCE
At Celyad Oncology, we are pursuing next-generation cellular immunotherapies by applying our broad understanding of immunology, novel technology platforms and modular design approach to drug discovery.
Novel CAR T Immunotherapies
Advancing both allogeneic and autologous CAR T therapy candidates for the treatment of cancer

Stay informed about the latest news!
Sign up FOR our newsletter
By clicking on “send”, you accept that your data will be sent to us and processed by our provider in order to send you our newsletter. You can find more information on how we process your data in our Privacy Policy.